Software

SURFactant Administration by SUPraglottic Airway (the SURFSUP 1 Trial): Statistical Analysis Plan

Monash University
Calum Roberts (Aggregated by) Joyce E O'Shea (Aggregated by) Kate Hodgson (Aggregated by) LOUISE OWEN (Aggregated by) Miranda Davies-Tuck (Aggregated by)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.26180/34818255.v1&rft.title=SURFactant Administration by SUPraglottic Airway (the SURFSUP 1 Trial): Statistical Analysis Plan&rft.identifier=https://doi.org/10.26180/34818255.v1&rft.publisher=Monash University&rft.description=The SURFSUP 1 Trial is a multi-centre, unblinded, randomised controlled, non-inferiority trial. The trial is investigating whether supraglottic airway surfactant treatment is non-inferior to minimally invasive surfactant treatment (MIST) provided by laryngoscopy and thin catheter, in preventing mechanical ventilation (MV) or repeat surfactant within 72 hours of randomisation, in preterm infants with a diagnosis of respiratory distress syndrome. The trial aimed to enrol at least 1000 preterm infants in 57 neonatal units in seven countries. Enrolment commenced in February 2021 and was completed in August 2026. Full details of the trial design are available in the trial protocol.RegistrationWHO Universal Trial Number: U1111-1258-2109ANZCTR Trial ID: ACTRN12620001184965&rft.creator=Calum Roberts&rft.creator=Joyce E O'Shea&rft.creator=Kate Hodgson&rft.creator=LOUISE OWEN&rft.creator=Miranda Davies-Tuck&rft.creator=PETER DAVIS&rft.creator=Peter Dargaville&rft.date=2026&rft_rights=CC-BY-4.0&rft_subject=statistical analysis plan (SAP)&rft_subject=surfactant treatment&rft_subject=respiratory distress syndrome (RDS)&rft_subject=supraglottic airways&rft_subject=minimally invasive surfactant therapy&rft_subject=Clinical trial [publication type]&rft_subject=Neonatology&rft.type=Computer Program&rft.language=English Access the software

Licence & Rights:

Open Licence view details
CC-BY

CC-BY-4.0

Full description

The SURFSUP 1 Trial is a multi-centre, unblinded, randomised controlled, non-inferiority trial. The trial is investigating whether supraglottic airway surfactant treatment is non-inferior to minimally invasive surfactant treatment (MIST) provided by laryngoscopy and thin catheter, in preventing mechanical ventilation (MV) or repeat surfactant within 72 hours of randomisation, in preterm infants with a diagnosis of respiratory distress syndrome. The trial aimed to enrol at least 1000 preterm infants in 57 neonatal units in seven countries. Enrolment commenced in February 2021 and was completed in August 2026. Full details of the trial design are available in the trial protocol.

Registration

WHO Universal Trial Number: U1111-1258-2109

ANZCTR Trial ID: ACTRN12620001184965

Issued: 2026-10-27

Created: 2026-10-27

This dataset is part of a larger collection

Click to explore relationships graph
Subjects

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Identifiers
ACN 633 798 857